Richard Foxton

Targeting key angiogenic pathways with a bispecific Cross <scp>MA</scp> b optimized for neovascular eye diseases

Jörg T. Regula, Peter Lundh von Leithner, Richard Foxton et al. · EMBO Molecular Medicine · 2016 · 333 citations · Full text

VEGF-A Is Necessary and Sufficient for Retinal Neuroprotection in Models of Experimental Glaucoma

Richard Foxton, Arthur Finkelstein, Sauparnika Vijay et al. · American Journal Of Pathology · 2013 · 193 citations · Full text

Spontaneous CNV in a Novel Mutant Mouse Is Associated With Early VEGF-A–Driven Angiogenesis and Late-Stage Focal Edema, Neural Cell Loss, and Dysfunction

Norihiro Nagai, Pete Lundh von Leithner, Kanako Izumi‐Nagai et al. · Investigative Ophthalmology & Visual Science · 2014 · 52 citations · Full text

BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes

Vivian K. Lee, Brett Hosking, Joanna Holeniewska et al. · Diabetologia · 2018 · 47 citations · Full text

Delineating effects of angiopoietin-2 inhibition on vascular permeability and inflammation in models of retinal neovascularization and ischemia/reperfusion

Jérémie Canonica, Richard Foxton, Marina Garcia Garrido et al. · Frontiers in Cellular Neuroscience · 2023 · 42 citations · Full text